bioAffinity Technologies, Inc. Common Stock (NASDAQ: BIAF) last traded at $3.99, down 15.56% on the session. The quote above updates while this page is open; the figures below are drawn from bioAffinity Technologies, Inc. Common Stock’s own filings and are restated only when a new one is published.
bioAffinity Technologies, Inc. Common Stock trades on NASDAQ under the ticker BIAF. Its market capitalisation is $32.33 million.
Valuation measures for bioAffinity Technologies, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $32.33M |
|---|---|
| Enterprise value | $33.75M |
| Price / sales | 5.48 |
| Price / book | 8.58 |
| Beta | 2.21 |
Trailing-twelve-month figures tagged in bioAffinity Technologies, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $5.90M |
|---|---|
| Net income (TTM) | -$15.19M |
| Operating margin | -209.82% |
| Return on equity | -402.92% |
| Cash | $2.43M |
Range and volume for BIAF over the past 52 weeks.
| 52-week high | $80.70 |
|---|---|
| 52-week low | $3.80 |
| Volume | 182.2K |
| Average volume | 3.63M |
| Previous close | $4.73 |
Invest a chosen dollar amount in bioAffinity Technologies, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell BIAF.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.